Top

generating

the breakthroughs to heal

Press releases

We’re meeting milestones in our quest to accelerate healing.

2025

2024

2023

2022

2021

2020

2019

24 October 2019

Noveome Biotherapeutics, Inc. Announces Appointment of Kevin E. McCracken as Senior Vice President of Operations

3 October 2019

Noveome Biotherapeutics, Inc. To Present At The 2019 Flagship Ophthalmology Innovation Summit

26 September 2019

Noveome Biotherapeutics, Inc. Initiates Phase 1 Open Label Clinical Trial Evaluating Intranasal Delivery of Lead Candidate ST266 Targeting the Optic Nerve and Brain

5 September 2019

Noveome Biotherapeutics, Inc. Announces Passing of Board Member, John H. McArthur

13 June 2019

Noveome Biotherapeutics, Inc. Announces the First Patient Dosed in Phase 2 Open Label Clinical Trial Evaluating Topical Ocular Delivery of ST266 For the Treatment of Persistent Corneal Epithelial Defects

9 May 2019

Noveome Biotherapeutics, Inc. Announces Publication of Further Preclinical Results Supporting the Neuroprotective Properties of ST266 in Retinal Ganglion Cells

9 April 2019

Noveome Biotherapeutics, Inc. Completes $15 Million Series D Financing to Advance Growing Pipeline of Next-Generation Biologics

2 April 2019

Noveome Biotherapeutics, Inc. to Present at the 18th Annual Needham Healthcare Conference

2018

24 May 2018

Study Advances Novel Treatment for Damaged Optic Nerve

27 April 2018

Patrick Welch Elected to Noveome Board of Directors

3 April 2018

State Grant to Fund Clinical Trials Through Pittsburgh-Israeli Collaboration